Order and Specimen Accessioning
Accessioning links specimens to orders and patients, where identification integrity determines whether every downstream result is attached correctly.
Laboratory software fails in two places that matter more than the rest: specimen identification, where a mislabeled tube produces a confidently wrong result attached to the wrong patient, and amended results, where a corrected value must reach whoever acted on the original. Both are handled poorly by systems designed around throughput.
Laboratories process volume where a single identification error can drive an incorrect treatment decision. Taction Software builds diagnostic lab software across accessioning, instrument integration, result reporting, and billing, with identification integrity and result correction treated as primary design concerns.

Our experts are ready to understand your business goals.






























































Diagnostic lab software covers laboratory operations: order receipt, specimen collection and accessioning, instrument interfacing and result capture, technologist review and release, result delivery to ordering providers, quality control and proficiency testing documentation, reference laboratory send-outs, and billing. The LIS is the core, and our lab information system development work covers that layer specifically. Our work sits within our broader healthcare software development practice.
Accessioning links specimens to orders and patients, where identification integrity determines whether every downstream result is attached correctly.
Instrument interfaces capture results directly from analyzers, eliminating transcription and enabling the throughput volume laboratories require.
Technologist review applies rules and delta checks before release, since autoverification without exception handling releases implausible results unexamined.
Amended results must reach whoever received the original, since a correction that arrives without notification leaves the wrong value in circulation.
LOINC coding supports interoperable result exchange, drawing on our LOINC reference work for standards mapping.
Reference lab send-outs need tracking through the external laboratory and back, since specimens sent out are frequently where turnaround visibility disappears.
Our diagnostic lab software services cover LIS capability, instrument integration, result delivery, quality documentation, and revenue operations. The area we prioritize is identification integrity from collection through accessioning, because errors introduced there are invisible downstream and produce results that look entirely valid. Engagements typically open with a review of collection labeling practice and current identification error rates.
We build positive identification workflow at collection and accessioning, since barcode-driven labeling at the patient prevents most identification errors.
Analyzer interfaces are built per instrument, since protocols and result formats vary substantially across vendors and instrument generations.
Rules configuration releases routine results while routing exceptions, with thresholds set by laboratory leadership rather than vendor defaults.
Delivery and amendment workflow ensures corrected results reach original recipients, using our HL7 integration services practice.
QC and proficiency documentation supports CLIA and accreditation, maintained continuously rather than assembled before inspection.
Laboratory billing has distinct medical necessity requirements, drawing on our payment processing work for collection workflow.
The benefits concentrate in identification integrity, turnaround visibility, and billing accuracy. Specimen identification errors are the most consequential laboratory failure and the hardest to detect after the fact. Send-out visibility and amended result handling are both common gaps. We publish no figures on error rates, turnaround, or collection performance, because those depend entirely on test menu, volume, and current practice.
Positive identification at collection prevents the mislabeling errors that produce confidently wrong results attached to the wrong patient.
Instrument integration and rules-based release reduce the manual steps between analyzer output and result availability to the ordering provider.
Correction workflow notifies original recipients, addressing the gap where an amended value is filed but the person who acted never learns.
Reference tracking maintains turnaround visibility for specimens sent externally, which is where status information most commonly disappears.
QC records maintained continuously support inspection readiness rather than requiring assembly during pre-inspection preparation.
Medical necessity documentation alignment reduces denials, which are a persistent margin issue given laboratory reimbursement pressure.
We deliver diagnostic lab software projects in gated phases so laboratory, quality, and revenue stakeholders approve direction before engineering cost accumulates. Discovery reviews identification practice at collection, since that determines whether downstream integrity is achievable at all. Instrument integration is scoped against your specific analyzer fleet, because interface capability varies enough that assumptions produce schedule failures.
Discovery reviews collection labeling practice, since identification errors introduced there are undetectable downstream and produce valid-looking results.
We inventory analyzers and interface capability, since protocols vary by vendor and generation and older instruments frequently require custom work.
Accessioning and review workflow is designed with technologists, balancing throughput against the exception handling quality requires.
Autoverification rules are configured with laboratory leadership, since release thresholds are clinical decisions rather than technical defaults.
Amendment workflow is tested explicitly, since correction delivery is exercised infrequently and fails silently when built without attention.
Rollout expands by section with turnaround monitoring and continuing support as test menus and instruments change.
Laboratories operate under CLIA, accreditation programs including CAP where applicable, and standard HIPAA obligations. Proficiency testing, quality control, and personnel competency documentation are examined during inspection. Billing carries medical necessity requirements distinct from other clinical services. Taction holds ISO 27001 certification and follows HIPAA-aligned engineering practice. Result amendment handling deserves specific attention since it affects clinical decisions already made.
Builds apply encryption, role-based access, and complete audit logging. Our HIPAA compliance software development practice defines these controls.
CLIA and accreditation requirements govern quality control, proficiency testing, and competency, with documentation examined during inspection.
Amended results must reach original recipients, since a correction filed without notification leaves clinical decisions based on superseded values.
Positive identification requirements exist because misidentification produces results that appear valid while belonging to a different patient entirely.
Laboratory billing requires diagnosis support for medical necessity, with advance beneficiary notice obligations where coverage is uncertain.
Deployments run on-premise, in your cloud tenancy, or hybrid, with network segmentation, signed container images, and documented penetration testing before release.
Taction Software was founded in 2013 and has spent over 12 years building healthcare software, delivering more than 200 healthcare projects from four US offices in Chicago, Cheyenne, Austin, and Sacramento, with ISO 27001 certification. Our relevant emphasis is identification integrity and amendment delivery, which are the two failures with direct patient consequence and the two most likely to be underbuilt in systems optimized for throughput. Our leadership brings more than 20 years of personal experience in the field.
We build positive identification at collection, since errors introduced there produce results that look entirely valid while being wrong.
We test correction workflow explicitly, since amended results reach original recipients only if that path was deliberately built and verified.
We build analyzer interfaces across vendor variation, which is the practical work in laboratory projects more than LIS logic itself.
Founded in 2013, we have concentrated on healthcare rather than treating it as one vertical among several, producing depth in clinical workflow.
Our billing work covers medical necessity documentation, which is where laboratory denials concentrate more than in coding accuracy.
ISO 27001 certification means security controls are documented and auditable, supporting your vendor risk assessment efficiently.
Diagnostic lab software pricing depends on test menu breadth, analyzer count, interface complexity, and whether billing is in scope. Instrument integration is frequently the largest component, since each analyzer may require distinct work regardless of how many share a vendor. Discovery produces an itemized, fixed-scope estimate with phase-level breakdown. Instrument interface licenses, cloud infrastructure, and terminology subscriptions are separate from engineering cost.
An MVP covering accessioning and one instrument interface typically runs $40,000 to $80,000, establishing the pattern before expansion.
A full platform with multi-instrument integration, result delivery, QC documentation, and billing typically falls between $80,000 and $200,000.
Enterprise engagements covering reference laboratory operations, multi-site networks, and full revenue integration start at $200,000.
Discovery is a paid, time-boxed phase producing an itemized estimate, architecture plan, and instrument inventory assessment.
Analyzer count, interface variation, test menu breadth, and billing scope are the largest variables, identified during discovery.
Post-launch instrument additions, menu changes, and support are quoted separately as a retainer sized to test volume and analyzer count.
If you are evaluating diagnostic lab software for accessioning, instrument integration, result delivery, or billing workflow, the fastest next step is a discovery call with our team. We will inventory analyzers and review identification practice, then return an itemized, fixed-scope estimate. Contact us to schedule that conversation.
Laboratory directors evaluating diagnostic lab software usually ask about instrument integration effort, autoverification safety, and how amended results are handled. The answers below reflect how we scope these projects.
Harder than it looks, and it dominates project effort. Protocols vary by vendor and generation, documentation quality is inconsistent, and older analyzers frequently need custom handling. We inventory your specific fleet during discovery rather than estimating from instrument count alone.
With properly configured rules and exception routing, yes, and it is necessary at volume. The risk is releasing implausible results because delta checks and limits were set loosely. Rules are configured with laboratory leadership as clinical decisions rather than accepted as vendor defaults.
By notifying everyone who received the original, not just filing the correction. An amended result that reaches the record but not the physician who already acted leaves a clinical decision based on a superseded value. We test that path explicitly since it is exercised infrequently.
An MVP covering accessioning and one interface runs $40,000 to $80,000. A full platform typically falls between $80,000 and $200,000. Enterprise reference laboratory deployments start at $200,000. Analyzer count and interface variation drive cost most.
Not necessarily. Established LIS platforms handle core laboratory operations well. Many gaps clients describe involve client reporting, send-out visibility, billing, or specific integrations, which are addressable alongside the existing LIS rather than by replacing it.
Through medical necessity documentation alignment at order entry, since laboratory denials concentrate in diagnosis support rather than coding errors. Capturing supporting diagnosis when the order is placed is substantially more effective than appealing denials afterward.
Your email address will not be published. Required fields are marked *
Our expert reaches out shortly after receiving your request and analyzing your requirements.
If needed, we sign an NDA to protect your privacy.
We request additional information to better understand and analyze your project.
We schedule a call to discuss your project, goals. and priorities, and provide preliminary feedback.
If you're satisfied, we finalize the agreement and start your project.